Aldesulfone sodium
From Wikipedia, the free encyclopedia
 |
|
|
Aldesulfone sodium
|
|
| Systematic (IUPAC) name | |
| [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid | |
| Identifiers | |
| CAS number | 144-75-2 |
| ATC code | J04BA03 |
| PubChem | 5351 |
| DrugBank | APRD00704 |
| Chemical data | |
| Formula | C14H16N2O6S3 |
| Mol. weight | 404.485 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 69% |
| Metabolism | Hepatic |
| Half life | 3 to 8 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Aldesulfone sodium (or sulfoxone) is an antibiotic used in the treatment of leprosy.
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
| Antimycobacterials (J04) edit | ||
|---|---|---|
| Tuberculosis: |
Aminosalicylic acid, Calcium aminosalicylate, Capreomycin, Cycloserine, Ethambutol, Ethionamide, Isoniazid, Morinamide, Protionamide, Pyrazinamide, Rifabutin, Rifampicin, Rifamycin, Rifapentin, Sodium aminosalicylate, Terizidone, Tiocarlide |
|
| Leprosy: |
Aldesulfone sodium, Clofazimine, Dapsone |
|
